Completed
Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder
NCT01093937
- Conditions
- Behavior, Bipolar Disorder, Bipolar and Related Disorders, +7 more
- Locations
-
- Centre for Addiction and Mental Health Toronto, Ontario, Canada